Injective INJ
Current Price
$4.26 +9.52%
$0.4800 Daily Range (11.27%)
$3.87$4.35
$115.00M Daily Volume
1,434 BTC
Vol/MktCap: 26.99%
Market Performance
0.38% Relative BTC Volume
The total volume of Injective is $115.00M over the past 24 hours, compared to $30.30B total Bitcoin volume.
Hourly Moving Average
8 SMA $4.29 -0.68%
13 SMA $4.27 -0.18%
21 SMA $4.20 +1.41%
55 SMA $4.00 +6.57%
144 SMA $3.86 +10.36%
Price Performance
-0.50% 1 Hour Change
$4.26 from $4.28
+13.58% 7 Day Change
$0.5784 from $3.68
+23.22% 14 Day Change
$0.9890 from $3.27
+47.11% 30 Day Change
$2.01 from $2.25
All Time High
March 14, 2024
$52.62 -91.90%
-$48.36 vs. now
24H Change
38.17M USD +9.84%
476 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
4.99 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
27.98M INJ
traded over past 24 hours
27.98% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $4.32, reflecting a significant 13.01% increase over the last 24 hours. The daily trading range has been between a low of $3.82 and a high of $4.35, indicating strong volatility and investor interest in the asset.
The trading volume stands at approximately 114.39 million, which constitutes 26.48% of the market cap, suggesting robust liquidity for INJ. The hourly moving averages indicate bullish momentum, with the 8 SMA at $4.22 showing a 2.34% increase, while longer-term averages also reflect positive gains, particularly the 144 SMA at $3.84 with a 12.59% rise.
Technical indicators such as the 1-hour RSI at 74 suggest that INJ is approaching overbought territory, which may lead to short-term corrections. However, the 7-day RSI at 59 and the strong price changes over 7 days (18.23%), 14 days (25.36%), and 30 days (49.38%) indicate a sustained upward trend in the medium term.
Injective's all-time high of $52.62, achieved in March 2024, provides a significant upside potential, yet it also underscores the volatility risks associated with such high valuations. Investors should note the recent strong performance but remain cautious of potential corrections given the overbought signals in the short term.
In conclusion, the current bullish trend, coupled with solid volume and positive moving averages, supports a Buy rating for Injective (INJ). However, investors should be prepared for possible short-term pullbacks and manage risk accordingly.
The trading volume stands at approximately 114.39 million, which constitutes 26.48% of the market cap, suggesting robust liquidity for INJ. The hourly moving averages indicate bullish momentum, with the 8 SMA at $4.22 showing a 2.34% increase, while longer-term averages also reflect positive gains, particularly the 144 SMA at $3.84 with a 12.59% rise.
Technical indicators such as the 1-hour RSI at 74 suggest that INJ is approaching overbought territory, which may lead to short-term corrections. However, the 7-day RSI at 59 and the strong price changes over 7 days (18.23%), 14 days (25.36%), and 30 days (49.38%) indicate a sustained upward trend in the medium term.
Injective's all-time high of $52.62, achieved in March 2024, provides a significant upside potential, yet it also underscores the volatility risks associated with such high valuations. Investors should note the recent strong performance but remain cautious of potential corrections given the overbought signals in the short term.
In conclusion, the current bullish trend, coupled with solid volume and positive moving averages, supports a Buy rating for Injective (INJ). However, investors should be prepared for possible short-term pullbacks and manage risk accordingly.
Updated 261 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Coinbase rebounds as altcoins surge with bitcoin holding above $80,000
Tokenization and digital asset-infrastructure stocks climbed as SEC Chair Paul Atkins signaled support for onchain finance rules.

S&P 500 hits $2.6T in call options as AI mania fuels massive gamma squeeze
The shift towards options-driven market dynamics suggests traditional valuation methods may lose relevance in short-term equity price movements.

Tokenized treasuries on Ethereum reach record $8B – Why it matters
Is demand for macro yield quietly setting up an Ethereum rotation this cycle?

These Catalysts Can Trigger The Next XRP Price Run, But Can It Reach $3?
Market analysts are identifying new catalysts that could propel XRP to explosive highs.